Coherus BioSciences, Inc. Business Finance Contracts & Agreements

Asset Purchase Agreement, by and between Coherus BioSciences, Inc. and Hong Kong King-Friend Industrial Company Ltd., dated as of June 26, 2024 (Filed With SEC on June 27, 2024)

Consent, Partial Release and Third Amendment to Loan Agreement dated as of February 5, 2024 among Coherus BioSciences, Inc., Biopharma Credit PLC, BPCR Limited Partnership and... (Filed With SEC on February 5, 2024)

Purchase and Sale Agreement, by and between Coherus BioSciences, Inc. and Sandoz Inc., dated January 19, 2024 (Filed With SEC on January 22, 2024)

Underwriting Agreement, dated as of May 16, 2023, among Coherus BioSciences, Inc. and J.P. Morgan Securities LLC and Citigroup Global Markets Inc., as representatives of the... (Filed With SEC on May 18, 2023)

Second Amendment and Waiver to Loan Agreement dated as of February 6, 2023, among Coherus BioSciences, Inc., the Collateral Agent and the Lenders party thereto (Filed With SEC on May 8, 2023)

First Amendment to Loan Agreement dated as of April 7, 2022 among Coherus BioSciences, Inc., the Collateral Agent and the Lenders party thereto (Filed With SEC on August 4, 2022)

Loan Agreement dated as of January 5, 2022 among the Company, the Guarantors, the Collateral Agent and the Lenders party thereto (Filed With SEC on January 7, 2022)

Indenture, dated as of April 17, 2020, between Coherus BioSciences, Inc. and U.S. Bank National Association, as trustee (Filed With SEC on April 17, 2020)

First Amendment to Credit Agreement, dated as of April 13, 2020, by and between Coherus BioSciences, Inc. and affiliates of Healthcare Royalty Partners (Filed With SEC on April 14, 2020)

Second Amendment to Convertible Note Purchase Agreement, dated as of April 13, 2020, among Coherus BioSciences, Inc., the Guarantors party thereto, HealthCare Royalty Partners... (Filed With SEC on April 14, 2020)

Credit Agreement, dated as of January 7, 2019, by and among the Company and the Lenders (Filed With SEC on January 11, 2019)

Underwriting Agreement, dated May 22, 2018, among Coherus BioSciences, Inc., J.P. Morgan Securities LLC and Citigroup Global Markets Inc (Filed With SEC on May 25, 2018)

Stock Purchase Agreement, dated as of November 30, 2017, by and between the Company and KBI Biopharma, Inc (Filed With SEC on December 5, 2017)

Registration Rights Agreement, dated as of November 30, 2017, by and between the Company and KBI Biopharma, Inc (Filed With SEC on December 5, 2017)

COHERUS BIOSCIENCES, INC. STOCK PURCHASE AGREEMENT (Filed With SEC on August 22, 2017)

COHERUS BIOSCIENCES, INC. REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 22, 2017)

COHERUS BIOSCIENCES, INC. 5,154,640 Shares of Common Stock Underwriting Agreement (Filed With SEC on February 13, 2017)

COHERUS BIOSCIENCES, INC. 3,500,000 Shares of Common Stock Underwriting Agreement (Filed With SEC on May 26, 2016)

Amendment Dated as of March 25, 2016 to Senior Convertible Note Purchase Agreement (Filed With SEC on May 9, 2016)

COHERUS BIOSCIENCES, INC., asIssuer, the Guarantors from time to time party hereto, as Guarantors AND HealthCare Royalty Partners III, L.P., MX II Associates LLC, KMG... (Filed With SEC on February 29, 2016)

COHERUS BIOSCIENCES, INC. STOCK PURCHASE AGREEMENT (Filed With SEC on September 14, 2015)

COHERUS BIOSCIENCES, INC. REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 14, 2015)

COHERUS BIOSCIENCES, INC. [] Shares of Common Stock Underwriting Agreement (Filed With SEC on March 30, 2015)

COHERUS BIOSCIENCES, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN ARTICLE I. PURPOSE,SCOPE AND ADMINISTRATION OF THE PLAN (Filed With SEC on October 24, 2014)

COHERUS BIOSCIENCES, INC. [ ] Shares of Common Stock Underwriting Agreement (Filed With SEC on October 24, 2014)

COHERUS BIOSCIENCES, INC. THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on September 25, 2014)

Category

Industry

Companies

Contracts

Coherus BioSciences, Inc. Business Finance Contracts & Agreements